JANEL CORP (JANL)
Headquartered in New York, NY, Janel Corporation was founded in 1974 and provides a range of services worldwide through its various subsidiaries. The firm adopted its current name in April 2015, previously known as Janel World Trade Ltd. Janel operates across three core business segments: Logistics, Manufacturing, and Life Sciences. The Logistics segment specializes in global cargo movement and supply chain management. This encompasses freight forwarding across air, ocean, and ground modalities, alongside customs brokerage, warehousing, distribution, and supplementary services such as customs filing, cargo insurance procurement, strategic logistics planning, product repackaging, and real-time shipment tracking. Within the Manufacturing division, the company develops and distributes mixing apparatus and equipment catering to diverse industries, including chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. Lastly, the Life Sciences segment is dedicated to the production and supply of monoclonal and polyclonal antibodies, diagnostic reagents, and other immunologic reagents crucial for biomedical research. This segment further supports academic and industrial research scientists through antibody manufacturing, and produces items for other life science enterprises on an original equipment manufacturer (OEM) basis.
Sector: Services-Business Services, NEC
Industry: Integrated Freight & Logistics
Janel Corporation
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 1.19M shares outstanding
Headquartered in New York, NY, Janel Corporation was founded in 1974 and provides a range of services worldwide through its various subsidiaries.
The firm adopted its current name in April 2015, previously known as Janel World Trade Ltd. Janel operates across three core business segments: Logistics, Manufacturing, and Life Sciences. The Logistics segment specializes in global cargo movement and supply chain management. This encompasses freight forwarding across air, ocean, and ground modalities, alongside customs brokerage, warehousing, distribution, and supplementary services such as customs filing, cargo insurance procurement, strategic logistics planning, product repackaging, and real-time shipment tracking. Within the Manufacturing division, the company develops and distributes mixing apparatus and equipment catering to diverse industries, including chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. Lastly, the Life Sciences segment is dedicated to the production and supply of monoclonal and polyclonal antibodies, diagnostic reagents, and other immunologic reagents crucial for biomedical research. This segment further supports academic and industrial research scientists through antibody manufacturing, and produces items for other life science enterprises on an original equipment manufacturer (OEM) basis.
Leadership
Darren C. Seirer
Chairman, Chief Executive Officer & President
Gerard van Kesteren
Director, Chair of Audit Committee, Senior Advisor to Logistics
Gregory B. Graves
Director
Gregory J. Melsen
Director, Chair of Nominating and Corporate Governance Committee
Employees
353
Country
US
Sector
Industrials
Website
janelcorp.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Grant/Award | 2.5K | -- | Oct 1, 2026 | |
| Director | Grant/Award | 2.5K | -- | Oct 1, 2026 | |
| Director | Grant/Award | 2.5K | -- | Oct 1, 2026 | |
| Director | Grant/Award | 2.5K | -- | Oct 1, 2026 | |
| Director | Grant/Award | 2.5K | -- | Oct 1, 2026 | |
| Director | Purchase | 300 | $15.0K | Sep 14, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
GRAVES GREGORY B Director | 7.9K | 0.7% | FORM 4 |
Shandy Nathan Colin CFO, Secretary, Treasurer | 100 | 0.0% | FORM 4 |
Insiders
- GRAVES GREGORY BDirector
- Miller Ryan KarenDirector
- Gonzalez John Joseph IIDirector
- van Kesteren GerardDirector
- MELSEN GREGORY JDirector
- Shandy Nathan ColinCFO, Secretary, Treasurer
based on 1.19M shares outstanding
30d Avg
804
60d Avg
626
90d Avg
546